These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 22017168

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.
    Chang YS, Kim HJ, Chang J, Ahn CM, Kim SK, Kim SK.
    Lung Cancer; 2007 Sep; 57(3):373-80. PubMed ID: 17513004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer.
    Jamieson NB, Brown DJ, Michael Wallace A, McMillan DC.
    Cytokine; 2007 Sep; 27(2-3):90-2. PubMed ID: 15242698
    [Abstract] [Full Text] [Related]

  • 7. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
    Kayacan O, Karnak D, Beder S, Güllü E, Tutkak H, Senler FC, Köksal D.
    Am J Clin Oncol; 2006 Aug; 29(4):328-35. PubMed ID: 16891858
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
    Huang F, Wang XL, Geng Y, Li MX.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer.
    Ostheimer C, Bache M, Güttler A, Reese T, Vordermark D.
    BMC Cancer; 2014 Nov 21; 14():858. PubMed ID: 25416631
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
    Kadoglou NP, Gerasimidis T, Golemati S, Kapelouzou A, Karayannacos PE, Liapis CD.
    J Vasc Surg; 2008 Jan 21; 47(1):55-62. PubMed ID: 18178454
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.
    Lee JG, Cho BC, Bae MK, Lee CY, Park IK, Kim DJ, Ahn SV, Chung KY.
    Lung Cancer; 2009 Jan 21; 63(1):106-10. PubMed ID: 18513823
    [Abstract] [Full Text] [Related]

  • 18. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T.
    Anticancer Res; 2000 Jan 21; 20(2B):1311-6. PubMed ID: 10810441
    [Abstract] [Full Text] [Related]

  • 19. Nesfatin-1 in advanced lung cancer patients with weight loss.
    Cetinkaya H, Karagöz B, Bilgi O, Ozgün A, Tunçel T, Emirzeoğlu L, Top C, Kandemir EG.
    Regul Pept; 2013 Feb 10; 181():1-3. PubMed ID: 23269222
    [Abstract] [Full Text] [Related]

  • 20. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
    Dalaveris E, Kerenidi T, Katsabeki-Katsafli A, Kiropoulos T, Tanou K, Gourgoulianis KI, Kostikas K.
    Lung Cancer; 2009 May 10; 64(2):219-25. PubMed ID: 18845357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.